Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial - Smolen, J S; Beaulieu, A; Rubbert-Roth, A (Lancet, 2008)
(9617):